FUTURECHEM CO.,LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16,180 KRW | -4.77% |
|
+10.90% | +53.36% |
| Sales 2022 | 12.57B 9.08M | Sales 2023 | 13.97B 10.08M | Capitalization | 233B 168M |
|---|---|---|---|---|---|
| Net income 2022 | -13.96B -10.08M | Net income 2023 | -6.71B -4.84M | EV / Sales 2022 | 14.6 x |
| Net cash position 2022 | 29.06B 20.98M | Net cash position 2023 | 22.29B 16.09M | EV / Sales 2023 | 15.1 x |
| P/E ratio 2022 |
-13.1
x | P/E ratio 2023 |
-34.7
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 86.36% |
More Fundamentals
* Assessed data
More news
| 1 day | -4.77% | ||
| 1 week | +10.90% | ||
| 1 month | +22.76% | ||
| 3 months | +71.40% | ||
| 6 months | +94.71% | ||
| Current year | +53.36% |
1 week
14 000.00
17 270.00
1 month
11 660.0017 270.00
Current year
7 960.0017 270.00
1 year
7 100.0017 270.00
3 years
6 120.0019 923.08
5 years
4 551.2819 923.08
10 years
4 551.2823 076.92
| Managers | Title | Age | Since |
|---|---|---|---|
Dae-Yoon Ji
CEO | Chief Executive Officer | 69 | - |
Young-Il Yoo
DFI | Director of Finance/CFO | 50 | 16-12-31 |
Cheol Kim
AUD | Comptroller/Controller/Auditor | 57 | 17-03-12 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Chul-Soo Lee
BRD | Director/Board Member | 64 | - |
Jun-Gi Jung
BRD | Director/Board Member | 71 | 19-03-23 |
Dae-Yoon Ji
CEO | Chief Executive Officer | 69 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 16,180 | -4.77% | 690,678 |
| 24-05-30 | 16,990 | +7.87% | 1,201,146 |
| 24-05-29 | 15,750 | -3.02% | 555,691 |
| 24-05-28 | 16,240 | +6.49% | 1,428,097 |
| 24-05-27 | 15,250 | +4.52% | 1,230,909 |
End-of-day quote Korea S.E., May 30, 2024
More quotes
FutureChem. Co.,Ltd is a Korea-based company principally engaged in the manufacture and distribution of radiopharmaceuticals. The Company manufactures radiopharmaceuticals including radiopharmaceuticals for diagnosis of various cancers such as lung cancer and for the early diagnosis of Parkinson's disease and Alzheimer's disease. The Company also produces medical automation modules such as cubes and disposable goods including disposable cassettes, reagent kits, radio-caps and kryptofix kits; productions of photon emission tomography (PET) and single photon emission computed tomography (SPECT) precursors for radiopharmaceuticals and other chemicals such as metal chelating agents, fluorescence probes, peptides.
Calendar
2024-08-12
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +53.36% | 259M | |
| -3.43% | 12.45B | |
| -3.17% | 8.22B | |
| +31.98% | 5.67B | |
| -10.03% | 4.11B | |
| -59.94% | 2.68B | |
| +11.23% | 2.68B | |
| -5.14% | 2.37B | |
| +18.91% | 2.06B | |
| -7.56% | 1.8B |
- Stock Market
- Equities
- A220100 Stock
